Among oncogenic networks implicated in CRC, the PI3K/AKT/mTOR (PAM) axis is one of the most frequently dysregulated pathways in several cancers, contributing to tumor growth, metastasis, and poor response to treatment11. The gene discussed is AKT1; the disease is cancer.